President, CEO and Chairman of MAKO Surgical Corp. (MAKO, Financial) Maurice R Ferre sells 7,925 shares of MAKO on 12/30/2009 at an average price of $11.54 a share.
MAKO SURGICAL CORP. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. MAKO's Tactile Guidance System includes an interactive tactile robotics-arm platform that utilizes tactile-guided robotics and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a keyhole incision. This FDA-cleared surgeon-interactive tactile robotic-arm system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics, and implants. Mako Surgical Corp. has a market cap of $368.5 million; its shares were traded at around $11.1 with and P/S ratio of 125.2.
MAKO SURGICAL CORP. is a medical device company that markets its advanced robotic-arm solution and implants for minimally invasive orthopedic knee procedures. MAKO's Tactile Guidance System includes an interactive tactile robotics-arm platform that utilizes tactile-guided robotics and patient-specific visualization to prepare the knee joint for the insertion and alignment of resurfacing implants through a keyhole incision. This FDA-cleared surgeon-interactive tactile robotic-arm system allows surgeons to provide an innovative tissue-sparing bone resurfacing therapy called MAKOplasty to a large, yet underserved patient-specific population suffering from early to mid-stage osteoarthritic knee disease. MAKO has an intellectual property portfolio of more than two hundred licensed or owned patent applications relating to the areas of computer assisted surgery, haptics, robotics, and implants. Mako Surgical Corp. has a market cap of $368.5 million; its shares were traded at around $11.1 with and P/S ratio of 125.2.
CEO Recent Trades:
- Sell:: President, CEO and Chairman Maurice R Ferre sold 12,000 shares of MAKO stock on 12/15/2009 at the average price of 10.46, the price of the stock has increased by 6.12% since.
- Sell:: President, CEO and Chairman Maurice R Ferre sold 5,000 shares of MAKO stock on 11/16/2009 at the average price of 9.23, the price of the stock has increased by 20.26% since.
- Sell:: President, CEO and Chairman Maurice R Ferre sold 5,000 shares of MAKO stock on 09/16/2009 at the average price of 9.23, the price of the stock has increased by 20.26% since.
- Sell:: President, CEO and Chairman Maurice R Ferre sold 5,000 shares of MAKO stock on 09/15/2009 at the average price of 8.47, the price of the stock has increased by 31.05% since.
Directors and Officers Recent Trades:
- Buy:: Director Frederic H Moll bought 10,000 shares of MAKO stock on 11/30/2009 at the average price of 8.58, the price of the stock has increased by 29.37% since.
- Buy:: Director Frederic H Moll bought 20,000 shares of MAKO stock on 11/20/2009 at the average price of 9.01, the price of the stock has increased by 23.2% since.
- Buy:: Director John Savarese bought 632,000 shares of MAKO stock on 08/19/2009 at the average price of 7.25, the price of the stock has increased by 53.1% since.
- Buy:: 10% Owner Venture Partners V Lp Skyline bought 758,000 shares of MAKO stock on 08/14/2009 at the average price of 7.25, the price of the stock has increased by 53.1% since.
- Sell:: SVP, Chief Visionary Officer Rony A Abovitz sold 4,234 shares of MAKO stock on 12/29/2009 at the average price of 11.39, the price of the stock has decreased by 2.55% since.
